Q2Y-46040-61961
6 vaccinations
4 coded responses
48 check-ins
2 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 502 / IA
- Registered
- 2020-12-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
AY4-64560-63393
Child or adolescent in my care · Female · 2022-06-24
VEB-27935-14564
Child or adolescent in my care · Female · 2022-06-24
Timeline
-
2020-12-17
Dose 1 — Pfizer-BioNTech
-
2020-12-24
Registered in v-safe
-
2020-12-24
Health check-in — day 7, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2020-12-31
-
2021-01-07
Dose 2 — Pfizer-BioNTech
-
2021-01-07
Survey response — day 21, dose 1MedDRA: Headache, SARS-CoV-2 test — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Mild headaches almost daily since December 26 · Healthcare visit (other): Went to go get Covid testedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-07
Report sent to call center — day 21, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-15
- 2021-01-22
-
2021-01-28
Survey response — day 21, dose 2MedDRA: Chills, Dyspnoea, Fatigue, Headache, Respiratory tract congestion, Rhinorrhoea, Unevaluable event — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Chills, headache, shortness of breath, fatigue, congestion/runny nose · Healthcare visit (other): Haven't had appt yetMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-28
Report sent to call center — day 21, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-04
- 2021-02-10
- 2021-02-11
- 2021-02-18
- 2021-02-22
- 2021-02-24
- 2021-04-08
- 2021-06-09
-
2021-06-09
Call successfulDoes not wish to fill out VAERS report
- 2021-07-09
-
2021-11-02
Dose 3 — Pfizer-BioNTech
-
2022-04-27
Dose 4 — Pfizer-BioNTech
-
2022-04-30
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2022-05-01
Health check-in — days 1–6 daily, dose 4Feeling: Good · Chills, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2022-05-02
- 2022-05-03
- 2022-05-04
- 2022-05-11
- 2022-05-18
- 2022-05-26
- 2022-06-01
- 2022-06-08
- 2022-07-27
- 2022-10-26
-
2022-11-01
Dose 5 — Pfizer-BioNTech
-
2022-11-02
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-11-03
Health check-in — days 1–6 daily, dose 5Feeling: Good · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2022-11-04
-
2022-11-05
Health check-in — days 1–6 daily, dose 5Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
- 2022-11-06
- 2022-11-07
- 2022-11-08
- 2022-11-17
- 2022-11-22
- 2022-11-29
- 2022-12-06
- 2022-12-13
- 2023-01-31
- 2023-05-02
-
2023-05-15
Dose 6 — Pfizer-BioNTech
-
2023-05-16
Health check-in — days 1–6 daily, dose 6Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2023-05-17
Health check-in — days 1–6 daily, dose 6Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2023-05-18
- 2023-05-20
- 2023-05-21
- 2023-05-22
-
2023-05-29
Survey response — day 14, dose 6MedDRA: Chills, Cough, Diarrhoea, Headache, Pain, Pyrexia, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2023-06-05
Survey response — day 21, dose 6MedDRA: Cough, Dyspnoea, Office visit, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-06-05
Call case (no matching report) — SuccessfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-06-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-06-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-06-12
- 2023-06-19
- 2023-06-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech | |
| 3 | 2021-11-02 | Pfizer-BioNTech | No |
| 4 | 2022-04-27 | Pfizer-BioNTech | No |
| 5 | 2022-11-01 | Pfizer-BioNTech | No |
| 6 | 2023-05-15 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 successful
1 wait over 3 months for a first call
Free text
Release 1 — day 21, dose 1
Symptoms: Mild headaches almost daily since December 26
Healthcare visit (other): Went to go get Covid tested
Release 3 — day 21, dose 2
Symptoms: Chills, headache, shortness of breath, fatigue, congestion/runny nose
Healthcare visit (other): Haven't had appt yet
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | SARS-CoV-2 test | ✓ | ✓ | ✓ |
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Vomiting | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release